Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · IEX Real-Time Price · USD
7.55
-0.19 (-2.45%)
At close: Apr 18, 2024, 4:00 PM
7.78
+0.23 (3.05%)
After-hours: Apr 18, 2024, 7:18 PM EDT
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $409.97 million as of April 18, 2024. Its market cap has increased by 18.66% in one year.
Market Cap
409.97M
Enterprise Value
180.45M
1-Year Change
18.66%
Ranking
Category
Stock Price
$7.55
Market Cap Chart
Since November 11, 2015, Voyager Therapeutics's market cap has decreased from $456.60M to $409.97M, a decrease of -10.21%. That is a compound annual growth rate of -1.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2024 | 420.30M | -3.00% |
| Apr 16, 2024 | 433.30M | -3.15% |
| Apr 15, 2024 | 447.40M | -2.27% |
| Apr 12, 2024 | 457.80M | -3.98% |
| Apr 11, 2024 | 476.80M | -0.56% |
| Apr 10, 2024 | 479.50M | -2.86% |
| Apr 9, 2024 | 493.60M | 0.33% |
| Apr 8, 2024 | 492.00M | -2.88% |
| Apr 5, 2024 | 506.60M | 2.18% |
| Apr 4, 2024 | 495.80M | -2.34% |
| Apr 3, 2024 | 507.70M | -5.65% |
| Apr 2, 2024 | 538.10M | -5.98% |
| Apr 1, 2024 | 572.30M | 13.21% |
| Mar 28, 2024 | 505.50M | -2.62% |
| Mar 27, 2024 | 519.10M | -4.59% |
| Mar 26, 2024 | 544.10M | 8.21% |
| Mar 25, 2024 | 502.80M | 2.78% |
| Mar 22, 2024 | 489.20M | -4.15% |
| Mar 21, 2024 | 510.40M | -9.18% |
| Mar 20, 2024 | 562.00M | 2.87% |
| Mar 19, 2024 | 546.30M | 10.68% |
| Mar 18, 2024 | 493.60M | -2.04% |
| Mar 15, 2024 | 503.90M | 1.63% |
| Mar 14, 2024 | 495.80M | -0.10% |
| Mar 13, 2024 | 496.30M | 0.55% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CareDx | 428.73M |
| Tourmaline Bio | 427.78M |
| Aveanna Healthcare Holdings | 427.08M |
| Mersana Therapeutics | 424.45M |
| Avid Bioservices | 424.34M |
| Harrow Health | 417.99M |
| Heron Therapeutics | 416.41M |
| ZimVie | 415.20M |